Selected article for: "present study and protein fragment"
Author: LI, Xunliang; LI, Pengchong; CAO, Liyan; BAI, Yunyun; CHEN, Huijie; LIU, He; REN, Xiaofeng; LI, Guangxing
Title: Porcine IL-12 plasmid as an adjuvant improves the cellular and humoral immune responses of DNA vaccine targeting transmissible gastroenteritis virus spike gene in a mouse model
  • Document date: 2019_9_2
    • ID: rme6b022_6
    Snippet: In the present study, we constructed eukaryotic expression plasmids encoding the N-terminal fragment (2,106 bp) of the TGEV S protein (S1) and the porcine IL-12 (pIL-12) protein. We aimed to evaluate the potential of TGEV S1 as a DNA vaccine and pIL-12 as an adjuvant in a mouse model [3, 10] . Our results may lay the foundation for further studies on nucleic acid vaccines and immunological adjuvants......
    Document: In the present study, we constructed eukaryotic expression plasmids encoding the N-terminal fragment (2,106 bp) of the TGEV S protein (S1) and the porcine IL-12 (pIL-12) protein. We aimed to evaluate the potential of TGEV S1 as a DNA vaccine and pIL-12 as an adjuvant in a mouse model [3, 10] . Our results may lay the foundation for further studies on nucleic acid vaccines and immunological adjuvants.

    Search related documents:
    Co phrase search for related documents
    • dna vaccine and immunological adjuvant: 1, 2, 3
    • dna vaccine and mouse model: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • dna vaccine and nucleic acid vaccine: 1, 2, 3
    • dna vaccine and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • dna vaccine and protein porcine: 1
    • dna vaccine and TGEV S1 potential: 1, 2
    • dna vaccine TGEV S1 potential and immunological adjuvant: 1, 2
    • dna vaccine TGEV S1 potential and mouse model: 1, 2
    • dna vaccine TGEV S1 potential and TGEV S1 potential: 1, 2
    • expression plasmid and mouse model: 1, 2, 3, 4
    • expression plasmid and present study: 1, 2, 3, 4, 5, 6, 7, 8
    • expression plasmid and protein porcine: 1
    • immunological adjuvant and mouse model: 1, 2, 3
    • immunological adjuvant and nucleic acid vaccine: 1
    • immunological adjuvant and TGEV S1 potential: 1, 2
    • immunological adjuvant nucleic acid vaccine and nucleic acid vaccine: 1
    • mouse model and present study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • mouse model and TGEV S1 potential: 1, 2
    • present study and protein porcine: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17